MedTrace Logo

Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile

NCT02616510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2018-12-11

No results posted yet for this study

Summary

The polycystic ovary syndrome (PCOS) is the most common endocrinopathy amongst women of reproductive age. PCOS is associated with various cardiovascular risk factors such as obesity, glucose intolerance, dyslipidemia hypertension and the metabolic syndrome. Whether these increased cardiovascular risk factors result in the development of actual cardiovascular disease in later life remains to be established.

Women with premature ovarian insufficiency (POI), experience menopause prior to the age of 40 years. Women with POI may exhibit dyslipidemia. A young age at menopause has been previously associated with increased cardiovascular morbidity and mortality.

Conditions

Interventions

PROCEDURE

cardiovascular screening

cardiovascular screening: serum, urine, ECG, carotid intima media thickness (IMT), cardiac ultrasound

Sponsors & Collaborators

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Bart Fauser, prof · UMC Utrecht

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02616510 on ClinicalTrials.gov